Other OTC - Delayed Quote USD

NanoLogix, Inc. (NNLX)

0.0000 0.0000 (0.00%)
At close: April 8 at 12:39 PM EDT
Advanced Chart
Loading Chart for NNLX
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0002
  • Volume 2,083
  • Avg. Volume 0
  • Market Cap (intraday) 158
  • Beta (5Y Monthly) -34.94
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0160
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NanoLogix, Inc., a biotechnology company, provides live cell and rapid diagnostics test kits that detects viable bacteria and other microorganisms. The company's products include BioNanoPore kit, which employs a water permeable membrane that works with organic and inorganic molecules, as well as proteins; and FlatPack Petri Plates that are used for the isolation and cultivation of various fastidious and non-fastidious microorganisms, as well as displays growth of aerobic and anaerobic microorganisms. Its products are used in medical, national defense, homeland security, pharmaceutical, industrial, veterinary, and environmental testing applications. The company sells its products to established medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments. NanoLogix, Inc. is based in Hubbard, Ohio.

nanologix.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about NanoLogix, Inc.

Related News

View More
View More

Performance Overview: NNLX

Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NNLX
99.00%
S&P 500
5.05%

1-Year Return

NNLX
99.00%
S&P 500
21.22%

3-Year Return

NNLX
100.00%
S&P 500
20.06%

5-Year Return

NNLX
100.00%
S&P 500
72.48%

Compare To: NNLX

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

NNLX
NanoLogix, Inc.
0.0000
0.00%
Mkt Cap 158
Industry Biotechnology
AGEN
Agenus Inc.
5.77
+8.66%
Mkt Cap 120.858M
Industry Biotechnology

Statistics: NNLX

View More

Valuation Measures

Annual
As of

  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -129.95%

  • Return on Equity (ttm)

    -213.57%

  • Revenue (ttm)

    1.27k

  • Net Income Avi to Common (ttm)

    -1.95M

  • Diluted EPS (ttm)

    -0.0160

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    178.19k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -579.58k

View More

Company Insights: NNLX

People Also Watch

MHTX Manhattan Scientifics, Inc.
0.0017
0.00%
 
INTK Industrial Nanotech, Inc.
0.0001
+9,900.00%
 
NNBP Nanobac Pharmaceuticals, Incorporated
0.0000
0.00%
 
NPHC Nutra Pharma Corp.
0.0001
0.00%
 
GSPI Green Star Products, Inc.
0.0015
0.00%
 
HYEG Hydrogen Engine Center, Inc.
0.0085
0.00%
 
XSNX NovAccess Global Inc.
0.0070
-9.09%
 
AVXT AVAX Technologies, Inc.
0.0001
0.00%
 
MRES Institute of Biomedical Research Corp.
0.0110
0.00%
 
RSPI RespireRx Pharmaceuticals Inc.
0.0009
0.00%
 
AMHD HLK Biotech Holding Group, Inc.
0.0010
0.00%
 
MRPI Mera Pharmaceuticals, Inc.
0.0000
0.00%
 
HDVY Health Discovery Corporation
0.0000
0.00%
 
SPOM SPO Global Inc.
0.0017
-19.05%
 
MCET MultiCell Technologies, Inc.
0.0000
0.00%
 
RGIN Regenicin, Inc.
0.0050
0.00%